Publications

International journal of epidemiology

Body mass index and breast cancer survival: a Mendelian randomization analysis.

01-12-2017

Nature genetics

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

01-12-2017

Oncotarget

PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.

28-11-2017

BMJ open

Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study.

14-11-2017

Breast cancer research : BCR

Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.

07-11-2017

Nature

Association analysis identifies 65 new breast cancer risk loci.

02-11-2017

International journal of cancer

Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium.

01-11-2017

Breast cancer research and treatment

The prognostic value of the tumour-stroma ratio in primary operable invasive cancer of the breast: a validation study.

01-11-2017

Diabetologia

Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study.

01-09-2017

Journal of the National Cancer Institute

Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.

01-08-2017

Primary care diabetes

Trends in breast cancer incidence among women with type-2 diabetes in British general practice.

01-08-2017

European journal of cancer (Oxford, England : 1990)

Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years.

01-06-2017

Nature genetics

Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk.

01-06-2017

Cancer research

BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.

01-06-2017

BMC public health

The role of Indonesian patients' health behaviors in delaying the diagnosis of nasopharyngeal carcinoma.

25-05-2017

Breast cancer research : BCR

An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation.

22-05-2017

Genetics in medicine : official journal of the American College of Medical Genetics

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.

01-05-2017

European journal of cancer (Oxford, England : 1990)

An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint^®).

01-04-2017

Oncotarget

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.

14-03-2017

Breast cancer research : BCR

The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.

09-03-2017

Nature

Rare and low-frequency coding variants alter human adult height.

09-02-2017

PloS one

Diabetes and Breast Cancer Subtypes.

12-01-2017

Breast cancer research and treatment

Erratum to: Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.

01-01-2017

Cancer treatment reviews

Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs.

01-01-2017

Oncotarget

Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.

06-12-2016

Journal of medical genetics

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.

01-12-2016

Scientific reports

rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk.

15-11-2016

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Consensus opinion on MRI simulation for external beam radiation treatment planning.

01-11-2016

Breast cancer research : BCR

Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.

18-10-2016

American journal of human genetics

Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.

06-10-2016

Breast cancer research : BCR

Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium.

03-10-2016

Breast cancer research and treatment

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.

01-10-2016

International journal of cancer

Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.

15-09-2016

Scientific reports

Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).

07-09-2016

Nature communications

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

07-09-2016

Human molecular genetics

An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.

01-09-2016

Cancer discovery

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.

01-09-2016

PloS one

Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.

25-08-2016

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.

10-08-2016

PLoS medicine

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.

01-08-2016

Scientific reports

Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk.

18-07-2016

The journal of pathology. Clinical research

High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium.

01-07-2016

Breast cancer research : BCR

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.

21-06-2016

PloS one

RAD51B in Familial Breast Cancer.

07-05-2016

Cancer causes & control : CCC

Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.

01-05-2016

Journal of medical genetics

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.

01-05-2016

Gynecologic oncology

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

01-05-2016

Nature communications

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.

27-04-2016

Nature genetics

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

01-04-2016

PloS one

The Impact of the Overall Radiotherapy Time on Clinical Outcome of Patients with Nasopharyngeal Carcinoma; A Retrospective Study.

01-04-2016

Body mass index and breast cancer survival: a Mendelian randomization analysis.

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.

Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study.

Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.

Association analysis identifies 65 new breast cancer risk loci.

Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium.

The prognostic value of the tumour-stroma ratio in primary operable invasive cancer of the breast: a validation study.

Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study.

Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.

Trends in breast cancer incidence among women with type-2 diabetes in British general practice.

Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years.

Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk.

BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.

The role of Indonesian patients' health behaviors in delaying the diagnosis of nasopharyngeal carcinoma.

An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation.

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.

An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint®).

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.

The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.

Rare and low-frequency coding variants alter human adult height.

Diabetes and Breast Cancer Subtypes.

Erratum to: Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.

Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs.

Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.

rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk.

Consensus opinion on MRI simulation for external beam radiation treatment planning.

Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.

Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.

Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium.

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.

Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.

Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.

Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.

Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk.

High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium.

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.

RAD51B in Familial Breast Cancer.

Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

The Impact of the Overall Radiotherapy Time on Clinical Outcome of Patients with Nasopharyngeal Carcinoma; A Retrospective Study.

This site uses cookies

An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint^®).